Related Experiment Video
Updated: May 31, 2026
08:45
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Defining a role for sphingosine kinase 1 in p53-dependent tumors
L A Heffernan-Stroud1, K L Helke, R W Jenkins
1Department of Molecular and Cellular Biology and Pathobiology, Medical University of South Carolina, Charleston, SC 29403, USA.
Oncogene
|July 19, 2011
Summary
The tumor suppressor p53 regulates sphingosine kinase 1 (SK1) levels. Targeting SK1 restores tumor-suppressing sphingolipids, inhibiting cancer growth and increasing lifespan in preclinical models.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The tumor suppressor p53 is frequently inactivated in cancer, hindering the development of targeted therapies.
- Bioactive sphingolipids, including ceramide and sphingosine-1-phosphate (S1P), are critical regulators of cell proliferation, apoptosis, and senescence.
- Understanding how p53 exerts its tumor-suppressive functions is vital for developing novel cancer treatments.
Purpose of the Study:
- To investigate the role of sphingosine kinase 1 (SK1) as a downstream target of p53 in cancer.
- To elucidate the impact of p53-dependent regulation of SK1 on bioactive sphingolipid metabolism and tumor progression.
Main Methods:
- Analysis of SK1 proteolysis in response to genotoxic stress in a p53-dependent manner.
- Assessment of SK1 levels and sphingolipid profiles in p53 null mice.
- Evaluation of the effects of SK1 deletion on tumor formation and lifespan in p53 null and heterozygous mice.
- Investigation of the molecular mechanisms underlying p53-mediated tumor suppression via SK1 inhibition.
Main Results:
- p53-dependent proteolysis of SK1 was observed upon genotoxic stress.
- p53 null mice exhibited elevated SK1 levels, decreased ceramide, and increased S1P, promoting tumor growth.
- SK1 deletion in p53 null mice abrogated thymic lymphomas and extended lifespan by approximately 30%.
- SK1 deletion also attenuated cancer formation in p53 heterozygote mice.
- Loss of SK1 led to increased sphingosine and ceramide, promoting cell cycle arrest and senescence.
Conclusions:
- Sphingosine kinase 1 (SK1) is a key downstream target of the p53 tumor suppressor.
- Targeting SK1 can restore sphingolipid homeostasis and exert tumor-suppressive effects.
- SK1 inhibition represents a potential therapeutic strategy for p53-deficient cancers.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...